Mol Cell Bio:紧密连接蛋白促进乳腺癌肝转移

2012-07-02 Beyond 生物谷

紧密连接蛋白与恶性肿瘤的发生和发展有着密切关系,Claudin蛋白是细胞间的紧密连接蛋白的主要结构之一。Claudin蛋白目前研究较多,其中与恶性肿瘤相关的Claudin蛋白主要有7种,不同的肿瘤组织表达的Claudin类蛋白种类、量是不同的,在研究恶性肿瘤诊断、治疗的新手段方面,Claudin蛋白有很大前景。 早期研究确定蛋白紧密连接-2(claudin-2)是乳腺癌肝转移的重要功能性调解因子

紧密连接蛋白与恶性肿瘤的发生和发展有着密切关系,Claudin蛋白是细胞间的紧密连接蛋白的主要结构之一。Claudin蛋白目前研究较多,其中与恶性肿瘤相关的Claudin蛋白主要有7种,不同的肿瘤组织表达的Claudin类蛋白种类、量是不同的,在研究恶性肿瘤诊断、治疗的新手段方面,Claudin蛋白有很大前景。

早期研究确定蛋白紧密连接-2(claudin-2)是乳腺癌肝转移的重要功能性调解因子。近来Mol Cell Bio杂志刊登的一项研究发现肝转移患者中claudin-2的表达水平升高,但皮肤转移患者claudin-2不表达,这是根据乳腺癌患者相匹配的原发肿瘤类型而定的。

此外,与骨骼或肺转移的癌症患者群相比,claudin-2特异表达在肝脏转移性乳腺癌细胞中。此外,减少claudin-2的表达,无论是在肿瘤细胞或原代肝细胞中,都会抑制这些异型细胞与肝细胞之间的相互作用。

最后,研究表明,claudin-2的细胞外循环部位对介导肿瘤细胞/肝细胞相互作用以及乳腺癌细胞在体内形成肝转移的能力是必不可少的。因此,在乳腺癌肝转移过程中,claudin-2在乳腺癌细胞和肝细胞之间相关作用过程中从紧密连接复合体状态转变成粘附分子来发挥作用。

doi:10.1128/​MCB.00299-12
PMC:
PMID:

Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes

Sébastien Tabariès, Fanny Dupuy, Zhifeng Dong, Anie Monast, Matthew G. Annis, et al.

We previously identified claudin-2 as a functional mediator of breast cancer liver metastasis. We now confirm that claudin-2 levels are elevated in liver metastases, but not in skin metastases, compared to their matched primary tumors in patients with breast cancer. Moreover, claudin-2 is specifically expressed in liver-metastatic breast cancer cells compared to populations derived from bone or lung metastases. The increased liver tropism exhibited by claudin-2 expressing breast cancer cells requires claudin-2 mediated interactions between breast cancer cells and primary hepatocytes. Furthermore, reducing claudin-2 expression, either in cancer cells or primary hepatocytes, diminishes these heterotypic cell-cell interactions. Finally, we demonstrate that the first claudin-2 extracellular loop is essential for mediating tumor cell/hepatocyte interactions and the ability of breast cancer cells to form liver metastases in vivo. Thus, during breast cancer liver metastasis, claudin-2 shifts from acting within tight-junctional complexes to functioning as an adhesion molecule between breast cancer cells and hepatocytes.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1958774, encodeId=59c81958e7448, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Feb 22 02:09:00 CST 2013, time=2013-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076114, encodeId=fccf20e611436, content=<a href='/topic/show?id=abf6945365f' target=_blank style='color:#2F92EE;'>#连接蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94536, encryptionId=abf6945365f, topicName=连接蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Tue Apr 23 19:09:00 CST 2013, time=2013-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868542, encodeId=6f081868542ce, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Mar 07 15:09:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916904, encodeId=fa91191690469, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Sep 30 20:09:00 CST 2012, time=2012-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443776, encodeId=f75c1443e7643, content=<a href='/topic/show?id=6b058150307' target=_blank style='color:#2F92EE;'>#肝转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81503, encryptionId=6b058150307, topicName=肝转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea155117075, createdName=ms6747015003810650, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=)]
    2013-02-22 维他命
  2. [GetPortalCommentsPageByObjectIdResponse(id=1958774, encodeId=59c81958e7448, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Feb 22 02:09:00 CST 2013, time=2013-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076114, encodeId=fccf20e611436, content=<a href='/topic/show?id=abf6945365f' target=_blank style='color:#2F92EE;'>#连接蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94536, encryptionId=abf6945365f, topicName=连接蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Tue Apr 23 19:09:00 CST 2013, time=2013-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868542, encodeId=6f081868542ce, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Mar 07 15:09:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916904, encodeId=fa91191690469, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Sep 30 20:09:00 CST 2012, time=2012-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443776, encodeId=f75c1443e7643, content=<a href='/topic/show?id=6b058150307' target=_blank style='color:#2F92EE;'>#肝转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81503, encryptionId=6b058150307, topicName=肝转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea155117075, createdName=ms6747015003810650, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1958774, encodeId=59c81958e7448, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Feb 22 02:09:00 CST 2013, time=2013-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076114, encodeId=fccf20e611436, content=<a href='/topic/show?id=abf6945365f' target=_blank style='color:#2F92EE;'>#连接蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94536, encryptionId=abf6945365f, topicName=连接蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Tue Apr 23 19:09:00 CST 2013, time=2013-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868542, encodeId=6f081868542ce, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Mar 07 15:09:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916904, encodeId=fa91191690469, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Sep 30 20:09:00 CST 2012, time=2012-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443776, encodeId=f75c1443e7643, content=<a href='/topic/show?id=6b058150307' target=_blank style='color:#2F92EE;'>#肝转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81503, encryptionId=6b058150307, topicName=肝转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea155117075, createdName=ms6747015003810650, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1958774, encodeId=59c81958e7448, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Feb 22 02:09:00 CST 2013, time=2013-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076114, encodeId=fccf20e611436, content=<a href='/topic/show?id=abf6945365f' target=_blank style='color:#2F92EE;'>#连接蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94536, encryptionId=abf6945365f, topicName=连接蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Tue Apr 23 19:09:00 CST 2013, time=2013-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868542, encodeId=6f081868542ce, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Mar 07 15:09:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916904, encodeId=fa91191690469, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Sep 30 20:09:00 CST 2012, time=2012-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443776, encodeId=f75c1443e7643, content=<a href='/topic/show?id=6b058150307' target=_blank style='color:#2F92EE;'>#肝转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81503, encryptionId=6b058150307, topicName=肝转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea155117075, createdName=ms6747015003810650, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=)]
    2012-09-30 sunylz
  5. [GetPortalCommentsPageByObjectIdResponse(id=1958774, encodeId=59c81958e7448, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Feb 22 02:09:00 CST 2013, time=2013-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076114, encodeId=fccf20e611436, content=<a href='/topic/show?id=abf6945365f' target=_blank style='color:#2F92EE;'>#连接蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94536, encryptionId=abf6945365f, topicName=连接蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Tue Apr 23 19:09:00 CST 2013, time=2013-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868542, encodeId=6f081868542ce, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Mar 07 15:09:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916904, encodeId=fa91191690469, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Sep 30 20:09:00 CST 2012, time=2012-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443776, encodeId=f75c1443e7643, content=<a href='/topic/show?id=6b058150307' target=_blank style='color:#2F92EE;'>#肝转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81503, encryptionId=6b058150307, topicName=肝转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea155117075, createdName=ms6747015003810650, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=)]

相关资讯

Mol Cancer Res:GSK-3或成黑色素瘤治疗新靶点

糖原合成酶激酶-3(glycogen synthase kinase-3,GSK-3)是一种多功能的丝氨酸/苏氨酸蛋白激酶,是细胞内多种信号转导通路中的重要成分,不仅参与细胞内糖代谢过程而且还参与细胞增殖、细胞分化和细胞凋亡等多种重要生理过程。 GSK-3活性受多种机制调节,其活性调节异常时可引起多种重大疾病如糖尿病、神经退行性疾病和肿瘤等。GSK-3已成为许多疾病治疗靶点,目前针对GSK-3靶

Mol Biol Rep:姜黄素抑制NF-κB信号通路抗乳腺癌转移

姜黄素是从姜科、天南星科中的一些植物的根茎中提取的一种化学成分,其中,姜黄约含3%~6%,是植物界很稀少的具有二酮的色素,为二酮类化合物。 近来有报道姜黄素具有抗多种类型癌症的作用,但这种抗癌作用的分子机制尚不完全清楚。最近发表在Molecular Biology Reports杂志上的一项研究中,研究人员评估分析了姜黄素对人类乳腺上皮细胞MCF-7细胞的作用。细胞经姜黄素处理后,MTT法检测肿

Mol Cancer:异黄酮代谢产物抑制血管生成

一直以来某些植物化学物质包括多酚类物质如黄酮类化合物被认为具有抗癌功效。近日,一新研究证实这些化合物通过抑制肿瘤血管生成发挥其保护作用。新研究中发现一种植物化学物质具有潜在的抗血管生成活性,这不仅对了解这些化合物预防肿瘤的作用机制,同时也为开发新的肿瘤治疗试剂铺平了道路。 在试图找出能降低癌症发病率和死亡率的植物化学物质的道路上,研究人员筛选出了一套迄今未经研究过的植物雌激素的代谢产物。在这项新

Mol Cancer Res:TNF-α诱导肾细胞癌上皮间质转化

肿瘤坏死因子的产生-α(TNF-α)主要由活化的单核/巨噬细胞产生,能杀伤和抑制肿瘤细胞的细胞因子。促进中性粒细胞吞噬,抗感染,引起发热,诱导肝细胞急性期蛋白合成,促进髓样白血病细胞向巨噬细胞分化,促进细胞增殖和分化,是重要的炎症介质,并参与某些自身免疫病的病理损伤。 TNF-α是一种具有抗肿瘤特性的细胞因子。而相比之下,肿瘤细胞或基质细胞低剂量地、缓慢生成肿瘤坏死因子可能会促进肿瘤生长和转移。

Mol Can Res:鳞状细胞癌侵袭转移新标志物α-catulin

上皮癌特指来源于外胚层和内胚层,发生于上皮细胞的恶性肿瘤。鳞状细胞癌(SCC)是人上皮癌最常见的类型之一。其中头部和颈部鳞状细胞癌(HNSCC),由于后期诊断死亡率居高不下,淋巴结转移的预后差,是一种最具侵略性的癌症类型。 所有癌症过程的发生,都涉及到局部侵袭和远端器官转移,而这两者与临床上肿瘤患者的生存最相关,但至于肿瘤侵袭转移的分子机制一直得不到良好的解释。 在Molecular Canc

Mol Cancer Res:GAS6/Axl信号轴在前列腺癌转移中起关键作用

在多种癌症中受体酪氨酸激酶Axl都过度表达,Axl主要在肿瘤细胞的增殖和侵袭过程中发挥作用。 早期研究数据表明,Axl和其配体生长阻滞特异性因子-6(GAS6)可能在建立有利于肿瘤转移性休眠的骨髓微环境中发挥作用。目前刊登在Molecular Cancer Research杂志上的一则研究中,研究人员发现转移性前列腺癌细胞株PC3和DU145L中Axl是高表达的,低转移性癌细胞系LNCaP中Ax